ulcerative colitis
The Impact of GLP-1s on Patients With IBD
Obesity, especially when manifested by visceral adipose tissue, seems to be associated with worse IBD outcomes.
MAY 12, 2025

What Not to Do to Your Gut in 2025
To help your patients, here’s a top 10 list of things they should not be doing to their ...
FEBRUARY 14, 2025

List of Advanced Rx Recommended For Moderate to Severe UC Expands
The AGA has released an updated guideline on pharmacologic management of adult outpatients with UC that, for the ...
FEBRUARY 4, 2025

Risankizumab and Tulisokibart for Ulcerative Colitis
We rarely discuss early trials, but this month we highlight a phase 2 trial that offers a promising new mechanism ...
JANUARY 23, 2025

Tulisokibart May Be a Promising Treatment For Ulcerative Colitis
Tulisokibart yielded significant and clinically meaningful differences from placebo in UC clinical remission during ...
DECEMBER 30, 2024

Major Health Plans Will Prefer Humira Biosimilars in 2025
The market dominance of Humira may finally be at an end, as payors make dramatic shifts in favor of biosimilars to ...
DECEMBER 12, 2024

New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UC
The AGA has released a new, updated guideline on pharmacologic management of adult outpatients with ulcerative ...
NOVEMBER 26, 2024

AGA Issues Guideline on Management of Pouchitis
Edward Barnes, MD, MPH, sat down with GEN’s Sarah Tilyou to discuss the AGA’s first-ever guideline on ...
NOVEMBER 22, 2024

Miguel Regueiro, MD, Picks His Favorite IBD Research From ACG 2024
Miguel Regueiro, MD, sat down with GEN to talk about some of his favorite studies focused on treating IBD.
NOVEMBER 19, 2024

How Should You Treat an IBD Patient Who Has IBS Symptoms?
Many patients with IBD experience IBS–type symptoms, and clinicians can have a difficult time teasing out the ...
NOVEMBER 12, 2024

New Data Bring Answers To Microbial Imbalance
Imbalances in the gut microbiome can have negative health consequences, but the jury is still out on how to best ...
NOVEMBER 4, 2024

Guselkumab Shows Maintenance Efficacy in Initial Induction Nonresponders
New data has found guselkumab can be successful as a maintenance therapy even in those who initially did not ...
OCTOBER 27, 2024
